FDAnews
www.fdanews.com/articles/147237-healthcare-ruling-could-mean-years-of-delay-for-biosimilars

Healthcare Ruling Could Mean Years of Delay for Biosimilars

June 15, 2012
If the U.S. Supreme Court decides to strike down the entire health care law it could delay the debut of biosimilars onto the U.S. market for months or even years — along with their potential to cut billions of dollars from the country’s total drug spending — especially if Congress devolves into partisan squabbling over re-enacting the biosimilars provisions.
Law360